MedPath

Stepping towards precision rehabilitation; Establishing potential benefits and safety of early cardiac rehabilitation in diabetics post acute coronary syndrome

Not Applicable
Conditions
Acute Coronary Syndrome
Cardiovascular - Coronary heart disease
Registration Number
ACTRN12624000389505
Lead Sponsor
Baker Heart and Diabetes Institute
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
All
Target Recruitment
70
Inclusion Criteria

1. 18-80 years
2. Fluent in English
3. Fulfills Universal definition for Type I myocardial infarction within 2 weeks of enrolment
4. Diagnosed with Type II Diabetes
5. Ability to perform a bout of exercise on a treadmill or bike
6. Access to the Internet and Smart phone

Exclusion Criteria

1. > 80 years of age
2. Stage V Chronic Kidney Disease
3. Liver disease with documented cirrhosis
4. Severe pulmonary disease (FEV < 50%)
4. Type I Diabetes
5. History of sustained ventricular tachycardia with haemodynamic collapse or aborted sudden cardiac death.
6. Pregnancy

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Proportion of participants who experience functional improvement at 6 months determined by change in exercise capacity[Cardiopulmonary exercise test (CPET) using stationary cycle and a standardized ramp test protocol and activity monitoring using accelerometer (ARTG actigraph). Baseline and 6 months post-randomization.]
Secondary Outcome Measures
NameTimeMethod
Change in self-reported quality of life metrics[HRQOL metrics via self-reported questionnaire via telehealth. Kansas City Cardiomyopathy Questionnaire, SF-36 questionnaire, (all questionnaires relate to quality-of-life self-assessment). This will be assessed as a composite outcome as a combination of each questionnaire. <br> Baseline, 3 months and 12 months post-randomization.];Cardiovascular mortality[Exercise will be performed using a cardiopulmonary exercise test on a treadmill. <br> Baseline and 6 months post-randomization.];Metabolic parameters [ HbA1c, fasting glucose, total cholesterol on blood test Baseline and 6 months post-randomization.];Visual analogue score assessing quality of life[Visual analogue scale with questions designed specifically for this study Baseline and 6 months post-randomization]
© Copyright 2025. All Rights Reserved by MedPath